Browsing Tag
Lakewood-Amedex Biotherapeutics
1 post
LABT lists on Nasdaq: Can Lakewood-Amedex Biotherapeutics’ Bisphosphocin class crack antibiotic resistance?
Lakewood-Amedex Biotherapeutics (LABT) lists on Nasdaq with Nu-3 antimicrobial targeting infected diabetic foot ulcers. Read what it means for AMR investors.